Published in Mutat Res on September 28, 2011
Cell type-dependent changes in CdSe/ZnS quantum dot uptake and toxic endpoints. Toxicol Sci (2015) 0.86
An ISA-TAB-Nano based data collection framework to support data-driven modelling of nanotoxicology. Beilstein J Nanotechnol (2015) 0.86
Mechanism-based genotoxicity screening of metal oxide nanoparticles using the ToxTracker panel of reporter cell lines. Part Fibre Toxicol (2014) 0.83
Appropriate in vitro methods for genotoxicity testing of silver nanoparticles. Environ Health Toxicol (2013) 0.82
Is the toxic potential of nanosilver dependent on its size? Part Fibre Toxicol (2014) 0.81
How should the completeness and quality of curated nanomaterial data be evaluated? Nanoscale (2016) 0.78
The use of the comet assay for the evaluation of the genotoxicity of nanomaterials. Front Genet (2015) 0.77
Genetic toxicity assessment of engineered nanoparticles using a 3D in vitro skin model (EpiDerm™). Part Fibre Toxicol (2016) 0.77
Silver nanoparticles: correlating nanoparticle size and cellular uptake with genotoxicity. Mutagenesis (2015) 0.76
Tracking stem cells with superparamagnetic iron oxide nanoparticles: perspectives and considerations. Int J Nanomedicine (2017) 0.76
Mutagenic Effects of Nanosilver Consumer Products: a new Approach to Physicochemical Properties. Iran J Pharm Res (2015) 0.75
Impact of nanosilver on various DNA lesions and HPRT gene mutations - effects of charge and surface coating. Part Fibre Toxicol (2015) 0.75
Undetactable levels of genotoxicity of SiO2 nanoparticles in in vitro and in vivo tests. Int J Nanomedicine (2014) 0.75
Critical review of the current and future challenges associated with advanced in vitro systems towards the study of nanoparticle (secondary) genotoxicity. Mutagenesis (2016) 0.75
Titanium dioxide nanoparticles: an in vitro study of DNA binding, chromosome aberration assay, and comet assay. Cytotechnology (2017) 0.75
Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol (2005) 7.28
Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano (2008) 5.68
Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano (2009) 5.22
Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem (2004) 3.52
Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B (2008) 3.07
Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects. Small (2009) 2.40
Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small (2009) 2.20
Cyto- and genotoxicity of ultrafine TiO2 particles in cultured human lymphoblastoid cells. Mutat Res (2006) 2.15
Ultrafine titanium dioxide particles in the absence of photoactivation can induce oxidative damage to human bronchial epithelial cells. Toxicology (2005) 2.12
Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials (2003) 2.12
PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol Lett (2009) 2.01
Formation of nucleoplasmic protein aggregates impairs nuclear function in response to SiO2 nanoparticles. Exp Cell Res (2005) 1.87
Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol Sci (2005) 1.83
Modification of gold nanorods using phosphatidylcholine to reduce cytotoxicity. Langmuir (2006) 1.79
Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol Sci (2007) 1.77
Surface coatings determine cytotoxicity and irritation potential of quantum dot nanoparticles in epidermal keratinocytes. J Invest Dermatol (2006) 1.74
Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management. Toxicol Lett (2007) 1.68
Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhal Toxicol (2008) 1.66
How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? Toxicol Sci (2008) 1.65
Cytokinesis-block micronucleus assay evolves into a "cytome" assay of chromosomal instability, mitotic dysfunction and cell death. Mutat Res (2006) 1.45
Occupational genotoxicity risk evaluation through the comet assay and the micronucleus test. Genet Mol Res (2003) 1.45
Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration. Biomaterials (2010) 1.42
DNA damaging potential of zinc oxide nanoparticles in human epidermal cells. Toxicol Lett (2009) 1.40
Single-walled carbon nanotubes: geno- and cytotoxic effects in lung fibroblast V79 cells. J Toxicol Environ Health A (2007) 1.37
Uptake of silica-coated nanoparticles by HeLa cells. J Nanosci Nanotechnol (2005) 1.36
Evidence that ultrafine titanium dioxide induces micronuclei and apoptosis in Syrian hamster embryo fibroblasts. Environ Health Perspect (2002) 1.34
Development of in vitro systems for nanotoxicology: methodological considerations. Crit Rev Toxicol (2009) 1.33
Genotoxicity of silver nanoparticles in Allium cepa. Sci Total Environ (2009) 1.28
Clastogenic and aneugenic effects of multi-wall carbon nanotubes in epithelial cells. Carcinogenesis (2008) 1.26
Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays. Part Fibre Toxicol (2011) 1.21
In vivo mutation assay based on the endogenous Pig-a locus. Environ Mol Mutagen (2008) 1.20
Confounding experimental considerations in nanogenotoxicology. Mutagenesis (2009) 1.19
Cellular uptake, cytotoxicity, and innate immune response of silica-titania hollow nanoparticles based on size and surface functionality. ACS Nano (2010) 1.18
Bactericidal effect of iron oxide nanoparticles on Staphylococcus aureus. Int J Nanomedicine (2010) 1.17
Effects of surface chemistry on cytotoxicity, genotoxicity, and the generation of reactive oxygen species induced by ZnO nanoparticles. Langmuir (2010) 1.10
Preclinical studies on safety of fullerene upon acute oral administration and evaluation for no mutagenesis. Toxicology (2006) 1.09
The limits of testing particle-mediated oxidative stress in vitro in predicting diverse pathologies; relevance for testing of nanoparticles. Part Fibre Toxicol (2009) 1.06
Disturbed mitotic progression and genome segregation are involved in cell transformation mediated by nano-TiO2 long-term exposure. Toxicol Appl Pharmacol (2009) 1.05
Genotoxicity and cytotoxicity of multi-wall carbon nanotubes in cultured Chinese hamster lung cells in comparison with chrysotile A fibers. J Occup Health (2010) 1.03
Evaluation of the toxic impact of silver nanoparticles on Japanese medaka (Oryzias latipes). Aquat Toxicol (2009) 1.03
Mutagenicity evaluation of metal oxide nanoparticles by the bacterial reverse mutation assay. Chemosphere (2010) 1.02
High-specificity and high-sensitivity genotoxicity assessment in a human cell line: validation of the GreenScreen HC GADD45a-GFP genotoxicity assay. Mutat Res (2006) 1.01
Cytotoxicity and genotoxicity of ultrafine crystalline SiO2 particulate in cultured human lymphoblastoid cells. Environ Mol Mutagen (2007) 1.01
Using carbon nanotubes to induce micronuclei and double strand breaks of the DNA in human cells. Nanotechnology (2009) 1.00
Different capacities for recombination in closely related human lymphoblastoid cell lines with different mutational responses to X-irradiation. Mol Cell Biol (1994) 0.99
Comparative genotoxicity of cobalt nanoparticles and ions on human peripheral leukocytes in vitro. Mutagenesis (2008) 0.97
Carbon nanotubes induce oxidative DNA damage in RAW 264.7 cells. Environ Mol Mutagen (2010) 0.97
A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins. Mutat Res (2011) 0.94
Genotoxicity and cytotoxicity of zinc oxide and titanium dioxide in HEp-2 cells. Nanomedicine (Lond) (2010) 0.94
Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells. J Hazard Mater (2009) 0.93
Effects of particle exposure and particle-elicited inflammatory cells on mutation in rat alveolar epithelial cells. Carcinogenesis (1997) 0.93
Studies on the in vitro genotoxicity of baytubes, agglomerates of engineered multi-walled carbon-nanotubes (MWCNT). Toxicol Lett (2008) 0.92
Synergistic genotoxicity caused by low concentration of titanium dioxide nanoparticles and p,p'-DDT in human hepatocytes. Environ Mol Mutagen (2010) 0.92
Clastogenicity, photo-clastogenicity or pseudo-photo-clastogenicity: Genotoxic effects of zinc oxide in the dark, in pre-irradiated or simultaneously irradiated Chinese hamster ovary cells. Mutat Res (2006) 0.91
In vitro and in vivo genotoxicity tests on fullerene C60 nanoparticles. Toxicol Lett (2009) 0.90
Cellular uptake and mutagenic potential of metal oxide nanoparticles in bacterial cells. Chemosphere (2011) 0.88
Adaptations of the in vitro MN assay for the genotoxicity assessment of nanomaterials. Mutagenesis (2011) 0.88
Multi-walled carbon nanotubes: Lack of mutagenic activity in the bacterial reverse mutation assay. Toxicol Lett (2008) 0.87
Mutagenicity of water-soluble ZnO nanoparticles in Ames test. J Toxicol Sci (2009) 0.84
Analysis of 75 marketed pharmaceuticals using the GADD45a-GFP 'GreenScreen HC' genotoxicity assay. Mutagenesis (2009) 0.84
Soluble iron modulates iron oxide particle-induced inflammatory responses via prostaglandin E(2 )synthesis: In vitro and in vivo studies. Part Fibre Toxicol (2009) 0.84
Pd (core)-Au (shell) nanoparticles catalyzed conversion of NADH to NAD+ by UV-vis spectroscopy--a kinetic analysis. Spectrochim Acta A Mol Biomol Spectrosc (2009) 0.82
The in vitro genotoxicity of orthopaedic ceramic (Al2O3) and metal (CoCr alloy) particles. Mutat Res (2010) 0.82
In vivo genotoxicity assessment of aluminium oxide nanomaterials in rat peripheral blood cells using the comet assay and micronucleus test. Mutagenesis (2009) 0.81
BC nanofibres: in vitro study of genotoxicity and cell proliferation. Toxicol Lett (2009) 0.81
Evaluation of genotoxic effects of oral exposure to aluminum oxide nanomaterials in rat bone marrow. Mutat Res (2009) 0.80
Dextran coated ultrafine superparamagnetic iron oxide nanoparticles: compatibility with common fluorometric and colorimetric dyes. Anal Chem (2011) 0.80
Acute toxicity and genotoxicity studies on poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanomaterials. Mutat Res (2010) 0.80
Mutagenicity of water-soluble FePt nanoparticles in Ames test. J Toxicol Sci (2007) 0.80
Further analysis of Ames-negative rodent carcinogens that are only genotoxic in mammalian cells in vitro at concentrations exceeding 1 mM, including retesting of compounds of concern. Mutagenesis (2010) 0.80
In vitro mutagenicity assessment of aluminium oxide nanomaterials using the Salmonella/microsome assay. Toxicol In Vitro (2010) 0.79
Lack of genotoxicity of carbon nanotubes in a pilot study. Anticancer Res (2008) 0.78
DNA-damaging activity and mutagenicity of 16 newly synthesized thiazolo[5,4-a]acridine derivatives with high photo-inducible cytotoxicity. Mutat Res (2007) 0.77
Genotoxicity testing of nanomaterials--conclusions. Nanotoxicology (2010) 0.77
Ultrafine Quartz-Induced Damage in Human Lymphoblastoid Cells in vitro Using Three Genetic Damage End-Points. Toxicol Mech Methods (2007) 0.77
Heterogeneity in the bioactivity of LH secreted by peripubertal rats. J Reprod Fertil (2000) 0.76
Monitoring of DNA damage in foundry and pottery workers exposed to silica by the alkaline comet assay. Am J Ind Med (2003) 0.76
Hitting the mark or falling short with nanotechnology regulation? Trends Biotechnol (2009) 0.76
Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med (2000) 23.10
A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet (1997) 10.93
Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science (1997) 6.00
Serological analysis of the subgroup protein of rotavirus, using monoclonal antibodies. Infect Immun (1983) 5.85
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann Intern Med (1982) 4.54
The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med (2001) 3.39
An extremely luminous panchromatic outburst from the nucleus of a distant galaxy. Science (2011) 3.09
Comparison of health status and quality of life of related versus paid unrelated living kidney donors. Am J Transplant (2013) 3.04
Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat Genet (2000) 2.53
Effects of age on brain volume and head circumference in autism. Neurology (2002) 2.44
Genotype/Phenotype analysis of a photoreceptor-specific ATP-binding cassette transporter gene, ABCR, in Stargardt disease. Am J Hum Genet (1999) 2.42
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect (2014) 2.13
The membrane of peroxisomes in Saccharomyces cerevisiae is impermeable to NAD(H) and acetyl-CoA under in vivo conditions. EMBO J (1995) 2.12
Chiral symmetry breaking in sodium chlorate crystallizaton. Science (1990) 1.92
T-cell control of IL-12p75 production. Scand J Immunol (2006) 1.92
Anti-stress activity of Ocimum sanctum Linn. Indian J Med Res (1981) 1.91
Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis (2001) 1.91
Asynchronous replication and allelic exclusion in the immune system. Nature (2001) 1.89
Nutritive value of leaf protein from lucerne (Medicago sativa). Growth responses in rats at different protein levels & to supplementation with lysine &-or methionine. Indian J Exp Biol (1969) 1.83
Kappa chain monoallelic demethylation and the establishment of allelic exclusion. Genes Dev (1998) 1.81
Type IV collagen of the glomerular basement membrane. Evidence that the chain specificity of network assembly is encoded by the noncollagenous NC1 domains. J Biol Chem (2000) 1.73
Medical thoracoscopy for undiagnosed pleural effusions: experience from a tertiary care hospital in north India. Indian J Chest Dis Allied Sci (2011) 1.70
Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long-term hemodialysis: a two-year outcome analysis. J Am Coll Cardiol (2001) 1.66
Adenocarcinoma of the uterine cervix compared with squamous cell carcinoma: a 12-year study in Southampton and South-west Hampshire. Cytopathology (2001) 1.62
The rod photoreceptor ATP-binding cassette transporter gene, ABCR, and retinal disease: from monogenic to multifactorial. Vision Res (1999) 1.61
Physico-chemical and pasting properties of starch from stored potato tubers. J Food Sci Technol (2010) 1.60
Prevention of posttransplant cytomegalovirus disease and related outcomes with valganciclovir: a systematic review. Am J Transplant (2008) 1.60
Diverse macular dystrophy phenotype caused by a novel complex mutation in the ELOVL4 gene. Invest Ophthalmol Vis Sci (2001) 1.58
Practolol in acute myocardial infarction. Acta Med Scand Suppl (1976) 1.57
Low grade gastric B-cell lymphoma of mucosa associated lymphoid tissue in immunocompromised patients. Histopathology (1996) 1.52
Cell Walls of Tobacco Cells and Changes in Composition Associated with Reduced Growth upon Adaptation to Water and Saline Stress. Plant Physiol (1989) 1.52
Charcot-Leyden crystals in fine needle aspiration cytology. Acta Cytol (1997) 1.48
A new xenograft model of myeloma bone disease demonstrating the efficacy of human mesenchymal stem cells expressing osteoprotegerin by lentiviral gene transfer. Leukemia (2007) 1.47
Human papillomavirus infection in Barrett's oesophagus in the UK: an infrequent event. J Clin Virol (2008) 1.46
Prophylactic use of gabapentin for prevention of succinylcholine-induced fasciculation and myalgia: a randomized, double-blinded, placebo-controlled study. J Postgrad Med (2012) 1.44
A multicentric study with arteether in patients of uncomplicated falciparum malaria. J Assoc Physicians India (2001) 1.44
Efficacy of various amendments for amelioration of fly-ash toxicity: growth performance and metal composition of Cassia siamea Lamk. Chemosphere (2004) 1.42
Emery-Dreifuss muscular dystrophy. Ann Neurol (1979) 1.42
The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg (1998) 1.42
Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice. Immunol Rev (1999) 1.41
A randomized, prospective trial of stapled lung reduction versus laser bullectomy for diffuse emphysema. J Thorac Cardiovasc Surg (1996) 1.41
An outbreak of rubella in chandigarh, India. Indian Pediatr (2014) 1.40
Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients. Am J Transplant (2014) 1.40
Antioxidant levels in blood and seminal plasma and their impact on sperm parameters in infertile men. Indian J Biochem Biophys (2010) 1.40
Acute onset of hematuria and proteinuria associated with multiorgan involvement of the heart, liver, pancreas, kidneys, and skin in a patient with Henoch-Schönlein purpura. Kidney Int (2007) 1.39
Antimicrobial resistance: COMs and OMFSs. Br Dent J (2016) 1.38
Management of extensive subcutaneous emphysema and pneumomediastinum by micro-drainage: time for a re-think? Singapore Med J (2007) 1.34
Juvenile muscular atrophy localized to arms. Arch Neurol (1980) 1.34
Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness. Int J STD AIDS (1999) 1.34
Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med (1999) 1.32
Uptake and impact of a new live attenuated influenza vaccine programme in England: early results of a pilot in primary school-age children, 2013/14 influenza season. Euro Surveill (2014) 1.32
Allele-specific expression patterns of interleukin-2 and Pax-5 revealed by a sensitive single-cell RT-PCR analysis. Curr Biol (2000) 1.31
Invasive aspergillosis in transplant recipients. Medicine (Baltimore) (1999) 1.31
An unusual cause of respiratory distress: live leech in the larynx. Anesth Analg (2000) 1.30
Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein. J Biol Chem (1999) 1.30
The chaperone protein BiP binds to a mutant prion protein and mediates its degradation by the proteasome. J Biol Chem (2000) 1.29
Genital tuberculosis in Indian infertility patients. Int J Gynaecol Obstet (2007) 1.27
DNA integrity and semen quality in men with low seminal antioxidant levels. Mutat Res (2009) 1.26
The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma. Blood (1995) 1.26
Fungal Infections After Liver Transplantation. Transplant Proc (1988) 1.24
Role of AKT1 in 17beta-estradiol- and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells. Biochem Pharmacol (1999) 1.23
Increased levels of thiols protect antimony unresponsive Leishmania donovani field isolates against reactive oxygen species generated by trivalent antimony. Parasitology (2007) 1.23
Confounding experimental considerations in nanogenotoxicology. Mutagenesis (2009) 1.19
Calorimetric methods for interpreting protein-ligand interactions. Methods Enzymol (1995) 1.16
Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas. Br J Cancer (2002) 1.16
Fatal infection due to extended-spectrum beta-lactamase-producing Escherichia coli: implications for antibiotic choice for spontaneous bacterial peritonitis. Clin Infect Dis (1999) 1.15
Effect of cement dust on the growth and yield of Brassica campestris L. Environ Pollut (1990) 1.15
Modulation of voltage-dependent Ca2+ channels in rabbit colonic smooth muscle cells by c-Src and focal adhesion kinase. J Biol Chem (1998) 1.14
Is the patient brain-dead? Emerg Med J (2006) 1.13
A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation. J Surg Res (1996) 1.13
Chemopreventive activity of Withania somnifera in experimentally induced fibrosarcoma tumours in Swiss albino mice. Phytother Res (2001) 1.13
Modulation of immunogenicity and antigenicity of proteins by maleylation to target scavenger receptors on macrophages. J Immunol (1995) 1.13
Evaluation of a rapid test for the detection of antibodies to human immunodeficiency virus type 1 and 2. Int J STD AIDS (1999) 1.12
Differential expressions of bilaterally unerupted supernumerary teeth. J Indian Soc Pedod Prev Dent (2011) 1.12
Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients. Clin Vaccine Immunol (2007) 1.11
Thrombocytopenia in liver transplant recipients: predictors, impact on fungal infections, and role of endogenous thrombopoietin. Transplantation (2000) 1.11
Control of an outbreak of infection due to extended-spectrum beta-lactamase--producing Escherichia coli in a liver transplantation unit. Clin Infect Dis (2001) 1.11
How to make a glycoinositol phospholipid anchor. Trends Biochem Sci (1992) 1.10
Cytomorphologic panorama of cysticercosis on fine needle aspiration. A review of 298 cases. Acta Cytol (1994) 1.10
Pharmacological studies to isolate the active constituents from Cyperus rotundus possessing anti-inflammatory, anti-pyretic and analgesic activities. Indian J Med Res (1971) 1.09
Evidence of immunity induced by naturally acquired rotavirus and Norwalk virus infection on two remote Panamanian islands. J Infect Dis (1985) 1.08
Diagnosis and management of tuberculosis in transplant donors: a donor-derived infections consensus conference report. Am J Transplant (2012) 1.08
Endogenous presenilin 1 redistributes to the surface of lamellipodia upon adhesion of Jurkat cells to a collagen matrix. Proc Natl Acad Sci U S A (1999) 1.07
Molecular profiling of cervical cancer progression. Br J Cancer (2007) 1.07
Effects of inhaled nitric oxide and oxygen in high-altitude pulmonary edema. Circulation (1998) 1.07
Effects of supplementing ragi (Eleusine coracana) diets with lysine or leaf protein on the growth and nitrogen metabolism of children. Br J Nutr (1969) 1.07
Further comments on the measurement of carotid stenosis from angiograms. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Stroke (1994) 1.06
Cimetidine therapy and duodenal candidiasis: role in healing process. Indian J Gastroenterol (1992) 1.06
Celebrities and screening: a measurable impact on high-grade cervical neoplasia diagnosis from the 'Jade Goody effect' in the UK. Br J Cancer (2013) 1.05
The Guillain-Barré syndrome following dengue fever. West Indian Med J (1999) 1.05
Infective endocarditis in solid organ transplant recipients. Clin Infect Dis (1998) 1.05
Factors affecting quality of life in patients with HIV infection. AIDS Read (2001) 1.05
New pre-pandemic influenza vaccines: an egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice. Clin Pharmacol Ther (2007) 1.04
Central cardiovascular effects of intracerebroventricular propranolol. Eur J Pharmacol (1973) 1.04
An unusual association between Mycobacterium tuberculosis and Aspergillus fumigatus. Monaldi Arch Chest Dis (2008) 1.04
A huffing manoeuvre, immediately before induction of anaesthesia, prevents fentanyl-induced coughing: a prospective, randomized, and controlled study. Br J Anaesth (2010) 1.03
A survey of CMV prevention strategies after liver transplantation. Am J Transplant (2007) 1.03